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Polo-like Kinase-2 Is Required for Centriole Duplication
in Mammalian Cells
is involved in embryonic development and cell cycle
progression [5], but the precise role of Plk2 remains
unknown.
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and Ingrid Hoffmann* To investigate the function of human Plk2 kinase, we
raised two polyclonal rabbit antibodies against the full-1Cell Cycle Control and Carcinogenesis, F045, and
2 Molecular Biology of the Cell II, A030 length protein and a C-terminal peptide sequence.
Western blotting of extracts from different exponentiallyGerman Cancer Research Center DKFZ
Im Neuenheimer Feld 242 growing human cells demonstrated that both antibodies
were specific for human Plk2 (hPlk2) in that they recog-D-69120 Heidelberg
Germany nized a major band at 78 kDa, the predicted molecular
weight of the protein that was increased in abundance3 Department of Biochemistry
University of Leicester after expression of recombinant hPlk2 (Figure S1 in the
Supplemental Data available with this article online). AUniversity Road
Leicester LE1 7RH nonspecific band that migrated slightly more rapidly was
also recognized in some cell types. The antibodies usedUnited Kingdom
were specific to Plk2 and did not crossreact with other
human Plks (data not shown). To examine the expres-
sion and kinase activity of hPlk2 during the cell cycle,Summary
we prepared extracts from HeLa cells that had been
arrested in prometaphase with nocodazole and thenCentriole duplication initiates at the G1-to-S transition
released for up to 16 hr. Western blotting revealed thatin mammalian cells and is completed during the S and
hPlk2 protein was expressed at equal abundance duringG2 phases. The localization of a number of protein
G1, S, and G2 phases (Figure 1A). In contrast, hPlk2kinases to the centrosome has revealed the impor-
kinase activity as determined in immunoprecipitatestance of protein phosphorylation in controlling the
with -casein as the substrate peaked as cells enteredcentriole duplication cycle. Here we show that the hu-
S phase and decreased again as cells entered G2 phaseman Polo-like kinase 2 (Plk2) is activated near the
(Figure 1A). No significant -casein activity was seen inG1-to-S transition of the cell cycle. Endogenous and
control immunoprecipitates with preimmune sera (dataoverexpressed HA-Plk2 localize with centrosomes,
not shown). The activity of hPlk2 appears simultaneouslyand this interaction is independent of Plk2 kinase ac-
with cyclin E expression and cyclin E-dependent kinasetivity. In contrast, the kinase activity of Plk2 is required
activity, strongly implying that hPlk2 is activated by afor centriole duplication. Overexpression of a kinase-
posttranslational mechanism at the onset of S phase.deficient mutant under S-phase arrest blocks centriole
Flow cytometry confirmed the synchrony of the samplesduplication. Downregulation of endogenous Plk2 with
(Figure 1B).small hairpin RNAs interferes with the ability to redupli-
To study the subcellular localization and function ofcate centrioles. Furthermore, centrioles failed to dupli-
hPlk2, we first overexpressed HA-epitope-tagged hPlk2cate during the cell cycle of human fibroblasts and
and HA-hPlk2dn (having a K111R point mutation in theU2OS cells after overexpression of a Plk2 dominant-
catalytic domain) in U2OS cells. Whereas hPlk2wt exhib-negative mutant. These results show that Plk2 is a
ited strong -casein activity, hPlk2dn was essentiallyphysiological centrosomal protein and that its kinase
inactive (Figure S2). Ectopic expression of both Plk2activity is likely to be required for centriole duplication
constructs revealed a pronounced centrosomal stain-near the G1-to-S phase transition.
ing. Confirmation that these HA-hPlk2-decorated organ-
elles are centrosomes was obtained by colocalization
Results and Discussion with -tubulin, an established centrosomal marker (Fig-
ure 1C). Similar results were also obtained when hPlk2
The mammalian centrosome consists of a pair of micro- was transfected into Chinese hamster ovary (CHO) cells
tubule-based centrioles and surrounding pericentriolar and were independent of the fixation method (data not
material. Duplication of a single centrosome must be shown). Anti-Plk2 antibodies, but not pre-immune sera,
precisely coordinated with the duplication of the ge- also produced strong labeling of centrosomes in U2OS
nome to ensure faithful transmission of genetic material. cells (Figure 1D). To confirm this observed localization,
Protein kinases play a pivotal role in the regulation of a biochemical approach was used. Centrosomes were
the centrosome cycle [1]. Among them are the polo- prepared from the KE37 human leukemic cell line by
like kinases (Plks) that control multiple important events sucrose gradient fractionation and analyzed by Western
during cell cycle progression. Mammalian cells contain blotting and immunofluorescence microscopy. On
at least three Polo family proteins, denoted Plk1 [2], Plk2 Western blots, both antibodies detected hPlk2 in centro-
(Snk) [3], and Plk3 (Fnk/Prk) [4]. Analysis of the growth some-enriched fractions (Figure 1E, left panel). As posi-
and development of Plk2/ mice indicated that Plk2 tive controls, established centrosomal proteins Nek2
and -tubulin were also shown to be present in centro-
some fractions [6], and the absence of the SR domain*Correspondence: i.hoffmann@dkfz.de
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splicing factor indicates that the centrosome prepara- inhibit centriole duplication ([8–10] and Figure 2C. We
suggest that hPlk2dn inhibits centriole duplication bytion is essentially free of nuclear contamination (Figure
1E, left). Immunofluorescent staining of these prepara- displacing the endogenously active hPlk2 from the cen-
trosome and/or by titrating out a key regulator or sub-tions with -tubulin, a specific marker of centrioles, re-
vealed a punctate staining of two closely neighbored strate into nonfunctional complexes. Similar results
were also obtained when U2OS cells were used insteadspots; such staining is characteristic of intact centro-
somes and precisely overlapped with that of -tubulin, of CHO cells in transient transfection experiments with
hPlk2dn (data not shown). The most straightforward in-confirming that hPlk2 localizes to centrosomes (Figure
1E, right). No centrosome staining was produced by the terpretation of these results is that centriole duplication
must depend on the activity of hPlk2. It was recentlycorresponding preimmune antibodies (Figure 1E).
Because hPlk2 kinase is present both in vitro and reported that human Plk1 is also required for centriole
duplication in U2OS cells [11]. However, in contrast toin vivo at the centrosome in interphase cells and its
kinase activity first appears at the G1/S boundary, we our results with hPlk2dn, we found that the bulk of cells
transfected with hPlk1dn contained more than two cen-anticipated that hPlk2 might be required for centriole
duplication. To test this hypothesis, we first asked trioles per cell (Figure 2C), suggesting that hPlk1dn does
not significantly interfere with centriole duplication. Thiswhether overexpression of wild-type hPlk2 could lead
to an alteration in centrosome number. Immunostaining falls in line with the fact that Plk1 kinase activity is low
during interphase but high during mitosis [12].with -tubulin antibodies revealed that 48 hr after trans-
fection, cells expressing hPlk2 did have noticeably more A recent report indicates that silencing of hPlk2 by
RNAi leads to apoptosis in the presence of taxol. Thiscentrosomes than untransfected cells (Figure 2A). How-
ever, although this could be interpreted to mean that effect might be explained by a failure to duplicate centri-
oles; this failure might lead to sensitization of cells tohPlk2 promotes centriole duplication, it could equally
result from hPlk2 interfering with cell cycle progression microtubule inhibitors in mitosis [13]. To further explore
a possible role of hPlk2 in centriole duplication, weor cytokinesis. We therefore decided to determine
whether the kinase-inactive hPlk2dn could act in a domi- asked whether downregulation of endogenous hPlk2
by RNA interference (RNAi) would prevent cells fromnant-negative manner to block centriole duplication.
One can use DNA synthesis inhibitors to experimentally reduplicating centrioles. To test this, we depleted hPlk2
mRNA in U2OS cells by using vectors that expresseduncouple centriole duplication from DNA replication in
certain cell types [7]. For example, CHO cells treated small hairpin RNAs (sh-RNAs) directed against two dis-
tinct hPlk2 coding sequences [14]. Transfection of eitherwith the DNA synthesis inhibitor hydroxyurea (HU) con-
tinue to duplicate their centrioles in the absence of DNA hPlk2 sh-RNA but not the control vector or lamin sh-
RNA (sh-lamin) resulted in a dramatic reduction of hPlk2replication. Expression of hPlk2dn into CHO cells with-
out HU treatment leads to a reduced number of centro- mRNA, leading to a quantitative decrease in the amount
of endogenous hPlk2 protein in the presence or absencesomes (Figure S3A). To determine if hPlk2 is involved
in centriole duplication, we transfected the hPlk2dn mu- of HU (Figure 3A). We then tested the effect of sup-
pressing endogenous hPlk2 expression on centriole du-tant into CHO cells before treatment with HU for 40 hr. As
shown in Figure 2B centriole duplication was markedly plication in the presence of HU. By 6 days after transfec-
tion, the level of hPlk2 had been reduced by 90% in theinhibited in CHO cells expressing HA-hPlk2dn. Dual indi-
rect immunofluorescence labeling by staining with the case of sh-Plk2(1) and by 75% in the case of sh-Plk2(2).
Centrosomes were visualized with -tubulin antibodiesPCM-marker -tubulin (Figure 2B, upper part) or by a
centriolar marker, i.e., antibodies against glutamylated after transfection of each Plk2 sh-RNA. We found that
both hPlk2 sh-RNAs disrupted the reduplication of cen--tubulin (Figure 2B, lower part) demonstrates that cen-
triole duplication has ceased in response to overexpres- trioles (Figures 3B and 3C). In contrast, vector alone or
sh-lamin did not affect centriole re-duplication. Cell cy-sion of Plk2dn. This would suggest a direct function of
Plk2 in centriole duplication. The level of inhibition by cle progression was not affected by either hPlk2 sh-
RNA in the presence or absence of HU, as shown byPlk2dn was almost identical to that induced by the
Cdk2dn kinase, which has been previously shown to flow-cytometric analysis (Figure S3B) or microscopic
On previous page.
Figure 1. Human Plk2 Kinase Is Activated at the G1/S Phase Boundary and Binds to Centrosomes Both In Vitro and In Vivo
(A) HeLa cells were released from nocodazole block into the next G1 phase. For Western blot analysis and kinase activity measurements,
samples were taken at the time points indicated. In the Plk2 immunoprecipitations -casein-P denotes phosphorylation of -casein by Plk2.
A Coomassie staining as loading control for the substrate -casein is shown below. For comparison, asynchronously growing cells (asn) were
analyzed in parallel.
(B) Samples from each time point were taken for flow cytometric analysis.
(C) Centrosomal localization of HA-hPlk2 was detected by anti-HA antibodies and centrosomes were visualized by staining with anti--tubulin
antibodies. Scale bar, 5 m.
(D) Immunofluorescent staining of U2OS cells with anti-Plk2-CDL21 antibodies or preimmune serum, anti--tubulin, and merge. Scale bar,
10 m.
(E) Centrosomes were isolated from KE37 human leukemic cells as described [19] and analyzed in Western blots in total cell extracts (T) and
centrosome factions (C) with hPlk2 preimmune serum (PI), antibodies against hPlk2 (Plk2-CDL21), -tubulin, Nek2, and SR domain. Isolated
centrosomes were probed with anti-Plk2-FL and -tubulin on total cell extracts (2 l) and purified centrosomes (left). Centrosome fractions
following isolation from KE37 cells were spun onto coverslips and double stained with anti-hPlk2-FL or preimmune and -tubulin (right).
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Figure 2. Overexpression of Plk2dn Blocks Centriole Reduplication
(A) Immunfluorescence showing overduplication of centrosomes after expression of Plk2 wild-type in U2OS (left) or CHO cells (right). Cells
were fixed and stained 48 hr after transfection. Scale bar, 5 m.
(B) CHO cells were transfected with plasmids encoding either HA-tagged hPlk2dn or with a plasmid expressing the HA tag alone in the
absence and presence of HU. Cells were stained with anti-HA antibody and either anti--tubulin (upper part) or with the GT335 antibody
(lower part). Centrosome numbers were quantified for all transfected cells using a Zeiss Axiophot microscope equipped with a 63 oil
immersion objective. Scale bar, 10 m.
(C) The histogram indicates the percentages of cells with more than two centrosomes after -tubulin staining, indicative of ongoing centriole
duplication. Data presented are the average of four independent experiments SD.
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Figure 3. RNAi-Mediated Suppression of hPlk2 Function Results in a Centriole Duplication Defect
(A) Western blotting demonstrates effective silencing of hPlk2 in U2OS cells. Cells were cotransfected in the presence of 2 g pBabe-puro
vector with 18 g pSuper-empty (control), pSuper-Lamin (sh-lamin), or pSuper-hPlk2 (sh-Plk2 (1) and sh-hPlk2 (2) [14]. After 24 hr, transfected
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plexes were then incubated with protein A-Sepharose on a rotatinginspection of the transfected cells. This experiment
wheel, spun down, and washed three times with lysis buffer.demonstrates that the block seen for centriole redupli-
For assaying human Plk2 kinase activity, hPlk2 immune com-cation when the Plk2 sh-RNAs were present is specific
plexes were washed once in kinase buffer (50 mM Tris/Cl [pH 7.5],
and cannot be explained by induction of a cell cycle 10 mM MgCl2, 10 M MnCl2, 1 mM DTT, and 10 mM -glycerolphos-
block caused by sh-RNA transfection. Thus, results from phate). Kinase reactions were carried out for 30 min at 30C in
kinase buffer supplemented with 10 M ATP, 2.5 Ci of [g32P]-overexpression of the dominant-negative hPlk2 mutant
ATP (Amersham), and 30 mg/ml of -casein (Sigma) as a substrate.and silencing of hPlk2 by RNAi concur to indicate that
Reactions were stopped by the addition of gel sample buffer andhPlk2 plays a specific role in promoting reduplication
heating at 95C for 5 min. Proteins were resolved by SDS-PAGE,
of centrioles. and [32P]-incorporation was visualized by autoradiography. Cdk2-
To address the role of Plk2 in normal centriole duplica- cyclin E complexes were immunoprecipitated with cyclin E antibody,
tion, we transfected a GFP-tagged hPlk2dn construct and histone H1 kinase activity was assayed as described [17, 18].
or GFP alone into human foreskin fibroblasts (Hs68).
Immunofluorescence, Centrosome Preparation,Immunfluorescence labeling with the centriole-specific
and Centriole Duplication Assaymarker GT335 revealed that the bulk of cells contained
Centrosomes were isolated from the human leukemic cell line KE37
either no centrioles or a single centriole after expression and processed for immunofluorescence microscopy according to
of hPlk2dn (Figure 4A). In fact, the percentage of Hs68 the method of Moudjou and Bornens [23]. From 109 cells, 3  108
centrosomes were recovered in the fractions eluted from the finalcells showing zero or one centriole increased to 65%
sucrose gradient. Isolated centrosomes were observed with a Nikonafter expression of GFP-hPlk2dn, as opposed to 21%
TE300 inverted microscope, and images were captured with anin control transfected cells (Figure 4B). Similar results
ORCA ER CCD camera (Hamamatsu, Japan) and Openlab 3.09 soft-
were also obtained when U2OS or hTERT BJ1 cells were ware (Improvision, U.K.).
used in centriole duplication assays (Figure S4). These For the centriole duplication assay, CHO cells were grown on
results suggest that centrioles failed to duplicate after coverslips treated with HCl. Calcium phosphate precipitates were
used for transfecting cells the following day with 20 g plasmidhPlk2dn expression and support a role of Plk2 in centri-
DNA. For quantification of the centrosome numbers, approximatelyole duplication in the normal cell cycle. We speculate
200 cells per experiment were counted. Cells were incubated inthat the appearance of cells with zero or one centriole
Ham’s F-12 medium. After an additional 10 hr, hydroxyurea was
is due to completion of one or more rounds of mitosis added to a final concentration of 4 mM. Cytoplasmic proteins were
in the absence of centriole duplication. However, it could extracted with extraction buffer (5 mM Pipes [pH 6.7], 2 mM EGTA,
and 0.75% Triton X-100), fixed for 10 min in ice-cold methanol 40 hrbe that expression of hPlk2dn somehow interferes with
after the addition of hydroxyurea (HU), and analyzed by immunofluo-polyglutamylation of centriolar microtubules and leads
rescence microscopy.to destabilization of centrosomes [15]. Determination of
Coverslips were blocked in 1% PBS/BSA, and cells were subse-
the substrates of hPlk2 relevant to centriole duplication quently stained for centrosomes with monoclonal anti--tubulin anti-
will ultimately be necessary to establish the mechanism bodies (Sigma, 1:10,000) and for overexpressed protein with mono-
clonal anti-HA antibody (Roche, 1:100). Centrioles were visualizedby which it regulates the centriole duplication cycle.
with an antibody against glutamylated -tubulin (GT-335, 1:5000)Taken together, our data provide the first evidence
[20]. Primary antibodies were detected with anti-mouse Alexa 488-that Plk2 kinase is required for centriole duplication.
conjugated (Molecular Probes), anti-mouse Texas Red-conjugated
Interestingly, Plk2/ mice are viable [5]. We anticipate (Jackson), or anti-rat Cy 3-conjugated (Jackson) secondary antibod-
that another family member, Plk3, which is expressed in ies. DNA was stained with DAPI. The mounted coverslips were ana-
lyzed by confocal microscopy (Zeiss [LMG50] Meta).early cell cycle phases, complements Plk2 in the Plk2/
mouse [3]. Deregulated hPlk2 kinase activity could pre-
siRNA Experimentssumably induce chromosomal instability by altering cen-
The Plk2-targeting vectors were based on a 19-mer sequence pres-trosome number and causing the formation of multipolar
ent in the coding sequence of human Plk2 [GGACATGGCTGTGAAT
mitotic spindles, a phenotype that has been observed CAG 	 sh-RNA(1), GAGCAGCTGAGCACATCAT	 sh-RNA(2)]. 64-
in human tumours [16]. Because Cdk2 kinase activity is mer synthetic oligonucleotides were synthesized, annealed, and
ligated into the pSuper construct as described [14]. For quantifica-known to be required for centriole duplication, it will be
tion of the centrosome numbers, approximately 200 cells per experi-intriguing to investigate whether Cdk2 and hPlk2 act in
ment were counted.a linear pathway and if hPlk2 is an in vivo substrate of
Cdk2 or vice versa. It will also be important to determine Supplemental Data
whether Plk2, like Cdk2, is required for initiating DNA Supplemental Data including Experimental Procedures and four fig-
replication as well as centriole duplication. ures are available at http://www.current-biology.com/cgi/content/
full/14/13/1200/DC1/.
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(C) Histogram comparing the efficiency of centrosome reduplication in the samples described above. Black bars indicate the percentage of
cells with normal numbers (1–2) of centrosomes, whereas grey bars denote cells with multiple centrosomes (
2). Shown are the averages of
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Figure 4. hPlk2 Regulates Centriole Duplication in Human Fibroblasts
Hs68 cells were transfected with pEGFP or pEGFP-Plk2dn by using Effectene (Qiagen) and fixed after 48 hr with methanol.
(A) Representative Hs68 cells expressing GFP alone or GFP-Plk2dn (green) showing staining with the GT335 antibody (red). Scale bar, 10 m.
(B) Centriole number was determined in Hs68 cells expressing GFP or GFP-Plk2dn. The percentage of cells showing none, one (black bars),
two, or more (grey bars) centrioles. Shown are the averages of four independent experiments SD.
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